InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for InSilico Medicine Cayman TopCo?
52 week high is the highest price of a stock in the past 52 weeks, or one year. InSilico Medicine Cayman TopCo 52 week high is $7.65 as of March 17, 2026.
What is the 52-week low for InSilico Medicine Cayman TopCo?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. InSilico Medicine Cayman TopCo 52 week low is $7.00 as of March 17, 2026.
What is InSilico Medicine Cayman TopCo stock price today?
InSilico Medicine Cayman TopCo stock price today is $7.00.
What was InSilico Medicine Cayman TopCo stock price yesterday?
InSilico Medicine Cayman TopCo stock price yesterday was $7.65.
What is the 50-day moving average of InSilico Medicine Cayman TopCo?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. InSilico Medicine Cayman TopCo 50-day moving average is $3.11.